Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.
- Presentation
Controversies in Acne and Rosacea: Discussion of BPO-containing Products and Formation of Benzene
Description
The discussion centers around the controversies surrounding benzoyl peroxide (BPO) products and their potential for benzene formation, particularly regarding their safety in acne and rosacea treatments. Dr. Kristen Bunick, an associate professor of dermatology at Yale, highlights recent regulatory concerns linked to benzene, a known carcinogen, increasingly identified in personal care items like hand sanitizers and sunscreens since the COVID-19 pandemic. The FDA has begun banning certain contaminated manufacturing materials while facing pressures from Congress for stricter regulations. Reports indicate BP can degrade into benzene in certain conditions, raising alarms about its long-term health effects, especially regarding its carcinogenic potential as seen in animal studies. Confounding messaging exists around acceptable benzene limits due to misinterpretations of FDA rules. Grounded studies indicate the systemic absorption of sunscreen ingredients and the risks posed by benzene exposure, raising questions on the safety of benzoyl peroxide-containing products. Notably, a recent analysis of the FDA's adverse event reporting system revealed a concerning correlation between certain BPO products and increased malignancy risk, although causality hasn't been established. The iteration underscores the need for further evaluation regarding the safety of BPO formulations, especially with regard to their benzene content, necessitating thoughtful storage and product handling to mitigate risks.
View moreConclusions
- Benzene has been found in numerous personal care products, including benzoyl peroxide, raising concerns about safety and regulations.
- The FDA has begun tightening regulations on benzene and formaldehyde in consumer products due to health risks.
- New policies may result in the ban of certain hair-straightening products linked to increased cancer risks, particularly for Black women.
- Existing FDA monographs allow unacceptable benzene levels, necessitating reformulation of affected products to ensure consumer safety.
- The FDA's stance is that benzene should not be present in products like benzoyl peroxide since its use is not essential for therapeutic advances.
- Benzoyl peroxide can form benzene when it decomposes, raising safety concerns regarding its use in acne treatment.
- High levels of benzene intake are linked to severe health issues, including leukemia and other blood-related cancers, necessitating immediate action from regulatory authorities.
- Consumer products found with benzene tend to exceed the accepted limits by considerable margins, highlighting regulatory failures.
- Ongoing research is needed to evaluate the extent of benzene absorption through the skin following the application of contaminated products.
- JAMA. 2020;323(3):256-267. doi:10.1001/jama.2019.20747
- J Am Acad Dermatol. 2022 Aug;87(2):440-443. doi: 10.1016/j.jaad.2021.09.003. Epub 2021 Sep 10.
- Chang MS, Moore KJ, Trepanowski N, Koru-Sengul T, Hartman RI. Sunscreen use is not associated with increased blood concentrations of benzene among adults in the United States: Data from the National Health and Nutrition Examination Survey 2003-2006 and 2009-2018. J Am Acad Dermatol. 2022 Aug;87(2):440-443. doi: 10.1016/j.jaad.2021.09.003. Epub 2021 Sep 10. PMID: 34509542.
- Sadr N, Troger A, Chai PR, Barbieri JS. No evidence for an association between benzoyl peroxide use and increased blood benzene levels in the National Health and Nutrition Examination Survey. J Am Acad Dermatol. 2024 Oct;91(4):763-765. doi: 10.1016/j.jaad.2024.06.050. Epub 2024 Jun 29.PMID: 38950699.
- Nakai JS, Chu I, Li-Muller A, Aucoin R. Effect of environmental conditions on the penetration of benzene through human skin. J Toxicol Environ Health. 1997 Aug 8;51(5):447-62. doi: 10.1080/00984109708984036.